Resectable pancreatic ductal adenocarcinoma
Clinical trials for Resectable pancreatic ductal adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Resectable pancreatic ductal adenocarcinoma trials appear
Sign up with your email to follow new studies for Resectable pancreatic ductal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets pancreatic cancer before surgery
Disease control Recruiting nowThis early-stage trial tests a drug called samuraciclib in 15 people with localized pancreatic cancer that can be surgically removed. Participants will take the drug for about two weeks before their planned surgery. Researchers will check safety and look for changes in tumor cell…
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase 1 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New scan could spot pancreatic cancer more clearly
Diagnosis Recruiting nowThis study tests a special PET scan that uses a radioactive tracer called 68Ga-FAPI-46 to highlight pancreatic cancer cells. The goal is to see if this scan can find tumors more accurately than current methods. About 130 adults with early-stage pancreatic cancer will get the scan…
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase 2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Genetic blueprint may unlock better pancreatic cancer care
Knowledge-focused Recruiting nowThis study looks at whether genetic information from tumors can help doctors choose better treatments for pancreatic cancer. About 200 adults with early or locally advanced pancreatic cancer will receive standard chemotherapy and provide blood, tissue, and fluid samples for genet…
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Pancreatic cancer drugs put to the test in early trial
Knowledge-focused Recruiting nowThis early phase trial is testing several targeted drugs in people with pancreatic cancer to see how they affect tumor biology. Researchers will compare tumor samples taken before and after treatment to understand which drugs might work best. The goal is not to treat the cancer d…
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Early phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC